670 related articles for article (PubMed ID: 22097965)
1. Toxicological considerations when creating nanoparticle-based drugs and drug delivery systems.
Sharma A; Madhunapantula SV; Robertson GP
Expert Opin Drug Metab Toxicol; 2012 Jan; 8(1):47-69. PubMed ID: 22097965
[TBL] [Abstract][Full Text] [Related]
2. Nanotechnology: a focus on nanoparticles as a drug delivery system.
Kingsley JD; Dou H; Morehead J; Rabinow B; Gendelman HE; Destache CJ
J Neuroimmune Pharmacol; 2006 Sep; 1(3):340-50. PubMed ID: 18040810
[TBL] [Abstract][Full Text] [Related]
3. Recent update of toxicity aspects of nanoparticulate systems for drug delivery.
Patnaik S; Gorain B; Padhi S; Choudhury H; Gabr GA; Md S; Kumar Mishra D; Kesharwani P
Eur J Pharm Biopharm; 2021 Apr; 161():100-119. PubMed ID: 33639254
[TBL] [Abstract][Full Text] [Related]
4. Safe Nanoparticles: Are We There Yet?
Najahi-Missaoui W; Arnold RD; Cummings BS
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33396561
[TBL] [Abstract][Full Text] [Related]
5. Lipid-based nanoparticles as pharmaceutical drug carriers: from concepts to clinic.
Puri A; Loomis K; Smith B; Lee JH; Yavlovich A; Heldman E; Blumenthal R
Crit Rev Ther Drug Carrier Syst; 2009; 26(6):523-80. PubMed ID: 20402623
[TBL] [Abstract][Full Text] [Related]
6. Unique benefits of nanotechnology to drug delivery and diagnostics.
McNeil SE
Methods Mol Biol; 2011; 697():3-8. PubMed ID: 21116949
[TBL] [Abstract][Full Text] [Related]
7. Clinical toxicities of nanocarrier systems.
Vega-Villa KR; Takemoto JK; Yáñez JA; Remsberg CM; Forrest ML; Davies NM
Adv Drug Deliv Rev; 2008 May; 60(8):929-38. PubMed ID: 18313790
[TBL] [Abstract][Full Text] [Related]
8. Toxicity of therapeutic nanoparticles.
Maurer-Jones MA; Bantz KC; Love SA; Marquis BJ; Haynes CL
Nanomedicine (Lond); 2009 Feb; 4(2):219-41. PubMed ID: 19193187
[TBL] [Abstract][Full Text] [Related]
9. Editorial of Special Issue "Surface-Functionalized Nanoparticles as Drug Carriers".
Layek B; Singh J
Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31861113
[TBL] [Abstract][Full Text] [Related]
10. Nanoparticles in drug delivery: past, present and future.
Couvreur P
Adv Drug Deliv Rev; 2013 Jan; 65(1):21-3. PubMed ID: 22580334
[TBL] [Abstract][Full Text] [Related]
11. Applications of nanosystems to anticancer drug therapy (Part II. Dendrimers, micelles, lipid-based nanosystems).
Ruiz ME; Gantner ME; Talevi A
Recent Pat Anticancer Drug Discov; 2014 Jan; 9(1):99-128. PubMed ID: 23578193
[TBL] [Abstract][Full Text] [Related]
12. Micro- and nanoparticles--medical applications.
Jătariu A; Peptu C; Popa M; Indrei A
Rev Med Chir Soc Med Nat Iasi; 2009; 113(4):1160-9. PubMed ID: 20191893
[TBL] [Abstract][Full Text] [Related]
13. Advances in the treatment of neurodegenerative disorders employing nanoparticles.
Spuch C; Saida O; Navarro C
Recent Pat Drug Deliv Formul; 2012 Apr; 6(1):2-18. PubMed ID: 22272933
[TBL] [Abstract][Full Text] [Related]
14. Nanotechnology in therapeutics: a focus on nanoparticles as a drug delivery system.
Bamrungsap S; Zhao Z; Chen T; Wang L; Li C; Fu T; Tan W
Nanomedicine (Lond); 2012 Aug; 7(8):1253-71. PubMed ID: 22931450
[TBL] [Abstract][Full Text] [Related]
15. Magnetic micro- and nano-particle-based targeting for drug and gene delivery.
Dobson J
Nanomedicine (Lond); 2006 Jun; 1(1):31-7. PubMed ID: 17716207
[TBL] [Abstract][Full Text] [Related]
16. Nanotechnology approaches for drug and small molecule delivery across the blood brain barrier.
Silva GA
Surg Neurol; 2007 Feb; 67(2):113-6. PubMed ID: 17254859
[TBL] [Abstract][Full Text] [Related]
17. Targeting of injectable drug nanocrystals.
Fuhrmann K; Gauthier MA; Leroux JC
Mol Pharm; 2014 Jun; 11(6):1762-71. PubMed ID: 24766270
[TBL] [Abstract][Full Text] [Related]
18. Safety and toxicity concerns of orally delivered nanoparticles as drug carriers.
Araújo F; Shrestha N; Granja PL; Hirvonen J; Santos HA; Sarmento B
Expert Opin Drug Metab Toxicol; 2015 Mar; 11(3):381-93. PubMed ID: 25495133
[TBL] [Abstract][Full Text] [Related]
19. Current understanding of interactions between nanoparticles and the immune system.
Dobrovolskaia MA; Shurin M; Shvedova AA
Toxicol Appl Pharmacol; 2016 May; 299():78-89. PubMed ID: 26739622
[TBL] [Abstract][Full Text] [Related]
20. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
